Pantoprazol Teva (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Teva, is a proton pump inhibitor presented as a unknown strength/oral tablet for oral use. It treats acid‑related disorders such as gastro‑oesophageal reflux disease and peptic ulcer disease in adult patients. GNH USA supplies Pantoprazol Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Pantoprazol Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Teva is a proton pump inhibitor used to manage conditions linked to excess gastric acid production.

- Gastro‑oesophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of the esophageal lining. - Erosive esophagitis: aids healing of erosive damage in the esophagus. - Peptic ulcer disease: supports ulcer healing and helps prevent recurrence. - Zoll‑Mellon  ​    ​  ​  ​ ​ ​ ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​​ - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: typically self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased gas production. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels: muscle cramps, irregular heartbeat. - Vitamin B12 deficiency: fatigue, neuropathy with long‑term use. - Fracture risk: increased incidence of hip, wrist or spine fractures with prolonged therapy. - Liver enzyme elevation: hepatitis‑like picture in rare cases.

Before taking Pantoprazol Teva, consider the following safety measures:

- Assess renal function: dose adjustment may be required in severe impairment. - Review liver status: monitor for hepatic dysfunction. - Evaluate pregnancy status: use only if clearly needed. - Monitor long‑term use: assess need for continued therapy after several months. - Consider drug‑interaction potential: check concomitant medications. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Pantoprazol Teva may interact with several medicines; clinical relevance varies.

Major Interactions (Avoid): - Ketoconazole oral: reduced absorption due to decreased acidity. - Atazanavir: diminished antiviral efficacy. - Clopidogrel: decreased antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR values. - Digoxin: increased serum concentrations. - Methotrexate: reduced renal clearance at high doses. - Phenytoin: altered metabolism. - Rifampin: may lower pantoprazole exposure.